Abbott Laboratories
MX ˙ BMV ˙ US0028241000
SecurityMX:ABT / Abbott Laboratories
InstitutionModera Wealth Management, LLC
Latest Disclosed Ownership103,865 shares
Latest Disclosed Value $ 10,663,809
Modera Wealth Management, LLC reports 1.37% decrease in ownership of ABT / Abbott Laboratories

On May 6, 2026 - Modera Wealth Management, LLC filed a 13F-HR form disclosing ownership of 103,865 shares of Abbott Laboratories (MX:ABT) valued at $10,663,809 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 21, 2026 disclosing 105,304 shares of Abbott Laboratories. This represents a change in shares of -1.37% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F ABBOTT LABORATORIES COM 002824100 103,865 -1,439 -1.37 10,664 -19.18 0.1278
2026-01-21 2025-12-31 13F ABBOTT LABS COM 002824100 105,304 -1,776 -1.66 13,194 -8.01 0.1526
2025-10-31 2025-09-30 13F ABBOTT LABS COM 002824100 107,080 -1,899 -1.74 14,342 -3.24 0.1662
2025-08-06 2025-06-30 13F ABBOTT LABS COM 002824100 108,979 62 0.06 14,822 2.60 0.1835
2025-05-08 2025-03-31 13F ABBOTT LABS COM 002824100 108,917 -1,915 -1.73 14,448 15.24 0.1954
2025-02-06 2024-12-31 13F ABBOTT LABS COM 002824100 110,832 -627 -0.56 12,536 -1.35 0.1514
2024-10-24 2024-09-30 13F ABBOTT LABS COM 002824100 111,459 -7,696 -6.46 12,707 2.63 0.1617
2024-07-29 2024-06-30 13F ABBOTT LABS COM 002824100 119,155 -6,945 -5.51 12,381 -13.61 0.1824
2024-05-14 2024-03-31 13F ABBOTT LABS COM 002824100 126,100 -4,102 -3.15 14,333 0.01 0.2183
2024-02-14 2023-12-31 13F ABBOTT LABS COM 002824100 130,202 -12,317 -8.64 14,331 3.83 0.2371
2023-11-30 2023-09-30 13F/A-1 ABBOTT LABS COM 002824100 142,519 5,842 4.27 13,803 -7.37 0.2602
2023-11-01 2023-09-30 13F ABBOTT LABS COM 002824100 142,519 5,842 13,803 0.2602
2023-08-07 2023-06-30 13F ABBOTT LABS COM 002824100 136,677 126,503 1,243.39 14,901 1,346.60 0.2705
2023-05-05 2023-03-31 13F ABBOTT LABS COM 002824100 10,174 135 1.34 1,030 -6.53 0.0400
2023-02-07 2022-12-31 13F ABBOTT LABS COM 002824100 10,039 71 0.71 1,102 14.20 0.0448
2022-11-01 2022-09-30 13F ABBOTT LABS COM 002824100 9,968 -543 -5.17 965 -15.50 0.0489
2022-07-27 2022-06-30 13F ABBOTT LABS COM 002824100 10,511 -1,344 -11.34 1,142 -18.60 0.0544
2022-05-03 2022-03-31 13F ABBOTT LABS COM 002824100 11,855 2,849 31.63 1,403 10.65 0.0621
2022-02-04 2021-12-31 13F ABBOTT LABS COM 002824100 9,006 220 2.50 1,268 22.16 0.0484
2021-11-04 2021-09-30 13F ABBOTT LABS COM 002824100 8,786 740 9.20 1,038 11.25 0.0533
2021-08-02 2021-06-30 13F ABBOTT LABS COM 002824100 8,046 6 0.07 933 -3.22 0.0503
2021-04-29 2021-03-31 13F ABBOTT LABS COM 002824100 8,040 -775 -8.79 964 -0.10 0.0627
2021-02-11 2020-12-31 13F ABBOTT LABS COM 002824100 8,815 2,954 50.40 965 51.25 0.0765
2020-11-12 2020-09-30 13F ABBOTT LABS COM 002824100 5,861 19 0.33 638 19.48 0.0946
2020-08-12 2020-06-30 13F ABBOTT LABS COM 002824100 5,842 -15 -0.26 534 15.58 0.0852
2020-05-12 2020-03-31 13F ABBOTT LABS COM 002824100 5,857 1,110 23.38 462 12.14 0.0969
2020-02-05 2019-12-31 13F ABBOTT LABS COM 002824100 4,747 -233 -4.68 412 -1.20 0.0644
2019-11-12 2019-09-30 13F ABBOTT LABS COM 002824100 4,980 0 0.00 417 -0.48 0.0693
2019-08-07 2019-06-30 13F ABBOTT LABS COM 002824100 4,980 0 0.00 419 5.28 0.0765
2019-05-13 2019-03-31 13F ABBOTT LABS COM 002824100 4,980 75 1.53 398 12.11 0.0745
2019-02-14 2018-12-31 13F ABBOTT LABS COM 002824100 4,905 0 0.00 355 -1.39 0.0699
2018-11-09 2018-09-30 13F ABBOTT LABS COM 002824100 4,905 88 1.83 360 22.45 0.0729
2018-08-09 2018-06-30 13F ABBOTT LABS COM 002824100 4,817 754 18.56 294 20.99 0.0620
2018-05-10 2018-03-31 13F ABBOTT LABS COM 002824100 4,063 14 0.35 243 5.19 0.0504
2018-02-05 2017-12-31 13F ABBOTT LABS COM 002824100 4,049 -400 -8.99 231 -2.53 0.0498
2017-11-14 2017-09-30 13F Abbott Laboratories COM 002824100 4,449 0 0.00 237 9.72 0.0534
2017-08-10 2017-06-30 13F ABBOTT LABS COM 002824100 4,449 -4,214 -48.64 216 -34.94 0.0525
2014-01-23 2013-12-31 13F ABBOTT LABS COM 002824100 8,663 8,663 332 0.1262
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.